All Xocova articles
-
News
Crowd-sourced potent SARS-CoV-2 antiviral lead compound announced by COVID Moonshot Consortium
More than 200 scientists and students, triggered by a Twitter appeal, have identified and developed novel compounds with excellent antiviral activity against a key enzyme of the SARS-COV-2 virus, the main protease (Mpro).
-
News
Study finds evidence of resistance to COVID-19 drugs
Resistance to Paxlovid is already evident among viral SARS-CoV-2 variants currently circulating globally, indicating that this stand-alone drug known as a protease inhibitor could soon become less effective in treating COVID-19 infections, a new study suggests.